Markets:

Overview

News

Currencies

International

Treasuries

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

5.890 -0.970 (-14.14%)

Streaming Delayed Price Updated: 1:06 PM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

< Previous 1 2 3 4 5 6 7 8 Next >

What's going on in today's after hours session ↗

March 14, 2025

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Phase 1 Trial for MS Treatment, Reports Positive Safety Results

February 26, 2025

Via Investor Brand Network

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

February 26, 2025

From Quantum BioPharma

Via GlobeNewswire

Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

February 18, 2025

From Quantum BioPharma

Via GlobeNewswire

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages MZ Group for Investor Relations Strategy

February 11, 2025

Via Investor Brand Network

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

February 11, 2025

From Quantum BioPharma

Via GlobeNewswire

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages Enterprise Canada, Empire Market Ventures for PR, Investor Awareness

February 10, 2025

Via Investor Brand Network

Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

February 10, 2025

From Quantum BioPharma

Via GlobeNewswire

Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge ↗

February 07, 2025

The company has attracted heavy attention after its dietary supplement, Unbuzzd, showed that it can reduce blood alcohol concentration rapidly in a clinical trial.

Via Stocktwits

Which stocks are moving on Thursday? ↗

February 06, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Quantum BioPharma Shares Are Up Over 80%: What's Going On? ↗

February 06, 2025

Quantum BioPharma shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial public offering.

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

February 06, 2025

Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

Thursday's session: top gainers and losers ↗

February 06, 2025

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Thursday's session: gap up and gap down stocks ↗

February 06, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Dow Edges Higher; US Weekly Jobless Claims Increase ↗

February 06, 2025

Via Benzinga

Topics Stocks

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Licensee Celly Nutrition Pursues $10M Capital Raise and U.S. IPO

February 06, 2025

Via Investor Brand Network

Topics Initial Public Offering

Which stocks are moving before the opening bell on Thursday? ↗

February 06, 2025

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.

Via Chartmill

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

February 06, 2025

From Quantum BioPharma

Via GlobeNewswire

These stocks have an unusual volume in today's session ↗

February 05, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session. ↗

February 04, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Quantum BioPharma Shares Are Up Today: What's Going On? ↗

February 04, 2025

Shares of Quantum BioPharma Ltd. (NASDAQ: QNTM) are soaring more than 70% on Tuesday after the company announced positive clinical trial results for its dietary supplement, unbuzzd, which accelerates...

Via Benzinga

Gold Moves Higher; Estée Lauder Shares Slide ↗

February 04, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

February 04, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates ↗

February 04, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

February 04, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Positive Clinical Trial Results for unbuzzd™

February 04, 2025

Via Investor Brand Network

Quantum BioPharma Stock Soars As Unbuzzd Trial Shows Rapid Fall In Blood Alcohol Levels, Retail Frenzy Ensues ↗

February 04, 2025

The company said it also led to a 67% reduction in headache severity at four hours and continued to ease cognitive and physical impairment up to eight hours after consumption.

Via Stocktwits

US Stocks Mixed; PepsiCo Posts Downbeat Sales ↗

February 04, 2025

Via Benzinga

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Quantum BioPharma Stock Is Soaring Tuesday: What's Driving The Action? ↗

February 04, 2025

Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for its unbuzzd dietary supplement.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.